Sasaki Takashi 佐々木敬

… Alternative Names

佐々木敬ササキタカシ

SASAKI Takashi 佐々木敬

Less

Researcher Number	90205849
Other IDs	https://orcid.org/0000-0002-1413-6983
External Links
Affiliation (Current)	2024: 公益財団法人佐々木研究所, 附属研究所, 理事長
Affiliation (based on the past Project Information) *help	2014 – 2018: 東京慈恵会医科大学, 医学部, 教授 2007: Jikei University School of Medicine, Department of medicine, Professor 2002 – 2006: Jikei University School of Medicine, Department of Internal Medicine, Assistant Professor, 医学部, 助教授 1999 – 2001: 東京慈恵会医科大学, 医学部, 講師 1996 – 1997: 東京慈恵会医科大学, 医学部, 助手 1994: 東京慈恵会医科大学, 医学部, 助手
Review Section/Research Field	Principal Investigator Metabolomics / Metabolomics / 内分泌・代謝学 Except Principal Investigator Metabolomics / Biomedical engineering/Biological material science / 内分泌・代謝学
Keywords	Principal Investigator インスリン / 再生医学 / 遺伝子 / 糖尿病 / インスリノーマ / adenoassociated virus / endocrine pancreas / cyclin-deuendent kinase / cvclin / insulin … More / aene therapy / cell cycle / reaenerative medicine / トランスレーショナルリサーチ / ウイルス / 膵臓 / ベータ細胞 / 増殖 / アデノ随伴ウイルス / 膵内分泌 / サイクリン依存性キナーゼ / サイクリン / 遺伝子治療 / 細胞周期 / 再生医療 / Mesenchyme / Precursor / Stem cell / Differentiation / Pancreas / Tissue Engineering / Insulin / Celltherapy / 前脂肪細胞 / レトロウイルスベクター / 細胞内輸送 / GFP / レトロウィルスベクター / レトロウイルス / 1型糖尿病 / 膵島移植 / フューリン / プロセッシング / プロホルモン / 間葉系 / 前駆細胞 / 幹細胞 / 分化 / 膵 / 再生 / 細胞治療 / HLA / Haplotype / TDT / Linkage Diseguilibrium / Transmission / Family Analysis / Genetic Instability / Genomic Imprinting / 抗GAD抗体 / ゲノムの不安定性 / IDDM / 膵島 / RT-PCR / データベース / RNA / 遺伝 / ゲノム / EST / PCR / 家系分析 / ハプロタイプ / インプリンティング / pancreatic islet / 培養 / シュワン細胞 / 神経堤 / 酸化ストレス / ゲノム編集 / gap junction / ブドウ糖応答性インスリン分泌 / Schwann細胞 / 膵島三次元構造 / 恒常性の破綻 / 自己組織化 / ブドウ糖応答性 / インスリン分泌 / 三次元培養法 / 膵島障害 … More Except Principal Investigator Insulin / furin / インスリン / AAV / Cytokeratin 19 / Bone marrow cells / Pancreatic duct cells / ngn-3遺伝子 / 細胞治療 / PDX-1遺伝子 / レーザーマイクロダイセクション / レーザーマククロダイセクション / 再生医学 / ネスチン / アデノ随伴ベクター / サイトケラチン / 骨髄細胞 / 膵管上皮細胞 / preadipocytes / Myoblasts / Cell device / hsp 70 promoter / Electrical stimulation / Gee expression / エンカプシレーション / 3T3L1細胞 / HSPプロモーター / レトロウイルス / 筋芽細胞 / 細胞デバイス / BIACORE法 / 電気刺激応答性 / hspプロモーター / 筋芽細胸 / 前脂肪細胞 / 遺伝子発現制御 / 抗GAD抗体 / genomic imprinting / HLA遺伝子 / IDDM Less

Function-structure relationship; role of the islet Schwann cellsPrincipal Investigator
- Principal Investigator
  
  Sasaki Takashi
- Project Period (FY)
  2014 – 2018
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Metabolomics
- Research Institution
  Jikei University School of Medicine
Inhibition of injury and promotion of regeneration in pancreatic islets of diabetes mellitus the by molecular interventionPrincipal Investigator
- Principal Investigator
  
  SASAKI Takashi
- Project Period (FY)
  2005 – 2007
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Metabolomics
- Research Institution
  Jikei University School of Medicine
Cell therapy for diabetes applied by pancreatic duct cells.
- Principal Investigator
  
  NEMOTO Masami
- Project Period (FY)
  2001 – 2004
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Metabolomics
- Research Institution
  Jikei University School of Medicine
Design and construction of cell device for inslin release to control of glycemia
- Principal Investigator
  
  AIZAWA Masuo
- Project Period (FY)
  2000 – 2001
- Research Category
  
  Grant-in-Aid for Scientific Research (A)
- Research Field
  
  Biomedical engineering/Biological material science
- Research Institution
  Tokyo Institute of Technology
Gene Therapy for diabetes mellitus with non-endocrine cellsPrincipal Investigator
- Principal Investigator
  
  SASAKI Takashi
- Project Period (FY)
  1999 – 2002
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Metabolomics
- Research Institution
  Jikei University School of Medicine
Genomic imprinting and instability in IDDMPrincipal Investigator
- Principal Investigator
  
  SASAKI Takashi
- Project Period (FY)
  1996 – 1997
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  内分泌・代謝学
- Research Institution
  Jikei University School of Medicine
日本人IDDMの遺伝におけるgenetic imprinting
- Principal Investigator
  
  TAJIMA Naoko
- Project Period (FY)
  1994
- Research Category
  
  Grant-in-Aid for General Scientific Research (C)
- Research Field
  
  内分泌・代謝学
- Research Institution
  Jikei University School of Medicine

All 2018 2017 2016 2015 2014 2007 2006 2000

All Journal Article Presentation

[Journal Article] SGLT2 inhibitor-induced changes in body composition and simultaneous changes in metabolic profile: 52-week prospective LIGHT Study with Luseogliflozin.2018
- Author(s)
  Sasaki T, Sugawara M, Fukuda M.
- Journal Title
  
  J Diabetes Investig.
  
  Volume: 9 Issue: 1 Pages: 108-117
- DOI
  10.1111/jdi.12851
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-26461346
[Journal Article] Sodium-glucose cotransporter-2 inhibitor luseogliflozin added to glucagon-like peptide 1 receptor agonist liraglutide improves glycemic control with bodyweight and fat mass reductions in Japanese patients with type 2 diabetes: A 52-week, open-label, single-arm study.2018
- Author(s)
  Seino Y, Yabe D, Sasaki T, Fukatsu A, Imazeki H, Ochiai H, Sakai S.
- Journal Title
  
  J Diabetes Investig.
  
  Volume: 9 Issue: 2 Pages: 338-340
- DOI
  10.1111/jdi.12694
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-26461346
[Journal Article] Pharmacokinetics and Pharmacodynamics of Luseogliflozin, a Selective SGLT2 Inhibitor, in Japanese Patients With Type 2 Diabetes With Mild to Severe Renal Impairment.2018
- Author(s)
  Samukawa Y, Haneda M, Seino Y, Sasaki T. Fukatsu A, Kubo Y, Sato Y, Sakai S.
- Journal Title
  
  Clin Pharmacol Drug Dev
  
  Volume: 7 Issue: 8 Pages: 820-828
- DOI
  10.1002/cpdd.456
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-26461346
[Journal Article] Sarcopenia, frailty circle and treatment with sodium-glucose cotransporter 2 inhibitors.2018
- Author(s)
  Takashi Sasaki
- Journal Title
  
  J Diabetes Investig
  
  Volume: 10 Issue: 2 Pages: 193-195
- DOI
  10.1111/jdi.12966
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-26461346
[Journal Article] Efficacy and safety of luseogliflozin added to insulin therapy in Japanese patients with type 2 diabetes: a multicenter, 52-week, clinical study with a 16-week, double-blind period and a 36-week, open-label period.2018
- Author(s)
  Seino Y, Sasaki T, Fukatsu A, Imazeki H, Ochiai H, Sakai S.
- Journal Title
  
  Curr Med Res Opin
  
  Volume: 34 Issue: 6 Pages: 981-994
- DOI
  10.1080/03007995.2018.1441816
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-26461346
[Journal Article] Sodium-glucose cotransporter 2 inhibitor-induced changes in body composition and simultaneous changes in metabolic profile: 52-week prospective LIGHT (Luseogliflozin: the Components of Weight Loss in Japanese Patients with Type 2 Diabetes Mellitus) Study.2018
- Author(s)
  Takashi Sasaki, Sugawara M, Fukuda M.
- Journal Title
  
  J Diabetes Investig
  
  Volume: 10
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-26461346
[Journal Article] SGLT2阻害薬ルセオグリフロジンの高齢2型糖尿病患者における安全性と有効性の検討　高齢者における特定使用成績調査(最終報告)2017
- Author(s)
  黒瀬健, 稲垣暢也, 深津敦司, 佐々木敬, 北島壮一, 清野裕
- Journal Title
  
  薬理と治療
  
  Volume: 45 Pages: 559-569
- Data Source
  KAKENHI-PROJECT-26461346
[Journal Article] SGLT2阻害薬によるケトン体の上昇の意味は?　心血管イベントのリスク減少機序としては、高ケトンよりも血圧低下、体液減少、交感神経の過緊張の解除が有力2017
- Author(s)
  佐々木敬
- Journal Title
  
  日本医事新報
  
  Volume: 4882 Pages: 62-63
- Data Source
  KAKENHI-PROJECT-26461346
[Journal Article] Modified Western blotting for insulin and other diabetes-associated peptide hormones.2017
- Author(s)
  Okita N, Higami Y, Fukai F, Kobayashi M, Mitarai M, Sekiya T, Sasaki T.
- Journal Title
  
  Sci Rep
  
  Volume: 7:6949 Issue: 1 Pages: 1-11
- DOI
  10.1038/s41598-017-04456-4
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-26461346, KAKENHI-PROJECT-17H02179
[Journal Article] 日本人2型糖尿病患者に対するSGLT2阻害薬ルセオグリフロジンの増量効果の検討　国内第III相52週投与試験の併合解析2017
- Author(s)
  佐々木敬, 玉置浩之, 坂井荘一, 寒川能成
- Journal Title
  
  Progress in Medicine
  
  Volume: 37 Pages: 769-776
- Data Source
  KAKENHI-PROJECT-26461346
[Journal Article] Efficacy and Safety of the SGLT2 Inhibitor Luseogliflozin in Japanese Patients With Type 2 Diabetes Mellitus Stratified According to Baseline Body Mass Index: Pooled Analysis of Data From 52-Week Phase III Trials2016
- Author(s)
  Soichi Sakai, Kohei Kaku, Yutaka Seino, Nobuya Inagaki, Masakazu Haneda, Takashi Sasaki, Atsushi Fukatsu, Haruka Kakiuchi, Yoshishige Samukawa
- Journal Title
  
  Clinical Therapeutics
  
  Volume: 38 Issue: 4 Pages: 843-862
- DOI
  10.1016/j.clinthera.2016.01.017
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-26461346
[Journal Article] High-throughput screening of small interfering ribonucleic acid identifies important modulators in islet dysfunction and apoptosis.2015
- Author(s)
  Masami Nemoto, Takashi Sasaki
- Journal Title
  
  Journal of Diabetes Investigation
  
  Volume: 6 Issue: 4 Pages: 390-392
- DOI
  10.1111/jdi.12283
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-26461346
[Journal Article] Epigenetics: Reprogrammable interface of the genome and environments.2014
- Author(s)
  Takashi Sasaki
- Journal Title
  
  Journal of Diabetes Investigation
  
  Volume: 5 Issue: 2 Pages: 119-120
- DOI
  10.1111/jdi.12150
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-26461346
[Journal Article] Genetic association of glutathione peroxidase-1 with coronary artery calcification in type 2 diabetes:a case control study with multi-slice computed tomography2007
- Author(s)
  根本昌実、佐々木敬、藤本啓、比企能人, ほか
- Journal Title
  
  Cardiovascular diabetology 6
  
  Pages: 23-29
- Description
  「研究成果報告書概要(和文)」より
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-17590948
[Journal Article] In vitro and Pathological Investigations of MODY5 with the R276X-HNF1β (TCF2) Mutation2007
- Author(s)
  Fujimoto, K., Sasaki, T., et. al.
- Journal Title
  
  Endocrine Journal 54
  
  Pages: 757-764
- NAID
  10020092977
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-17590948
[Journal Article] In vitro and Pathological Investigations of MODY5 with the R276X-HNF1β (TCF2) Mutation2007
- Author(s)
  藤本啓、佐々木敬、根本昌実、比企能人, ほか
- Journal Title
  
  Endocr J 54
  
  Pages: 757-764
- NAID
  10020092977
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-17590948
[Journal Article] In vitro and Pathological Investigations of MODY5 with the R276X-HNF1β(TCF2)Mutation2007
- Author(s)
  藤本啓、佐々木敬、根本昌実、比企能人, ほか
- Journal Title
  
  Endocr J 54
  
  Pages: 757-764
- NAID
  10020092977
- Description
  「研究成果報告書概要(和文)」より
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-17590948
[Journal Article] Genetic association of glutathione peroxidase-1 with coronary Artery calcification in type 2 diabetes : a case control study with multi-slice computed tomography2007
- Author(s)
  Nemoto, M., Sasaki, T., et. al.
- Journal Title
  
  Cardiovascular Diabetology 6
  
  Pages: 23-29
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-17590948
[Journal Article] 治療へのアプローチ、インスリン製剤-開発と治療法の進歩2000
- Author(s)
  佐々木敬
- Journal Title
  
  日本内科学会雑誌 89
  
  Pages: 1544-1550
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-12358015
[Presentation] SGLT2阻害薬ルセオグリフロジンの長期使用における安全性と有用性の検討　長期使用に関する特定使用成績調査(中間報告)2017
- Author(s)
  黒瀬健, 稲垣暢也, 深津敦司, 佐々木敬, 笠井良樹, 北島壮一, 清野裕
- Organizer
  第60回日本日本糖尿病学会学術集会（5月、名古屋）
- Data Source
  KAKENHI-PROJECT-26461346
[Presentation] 健常者における麦飯と主菜の併用による食後血糖上昇の検討2017
- Author(s)
  杉原聡子, 石崎知子, 早乙女恵, 細田暁彦, 種村陽子, 篠田良行, 小川篤美, 赤石定典, 湯浅愛, 小沼宗大, 濱裕宣, 佐々木敬, 吉田博
- Organizer
  第39回日本臨床栄養学会総会（10月、幕張）
- Data Source
  KAKENHI-PROJECT-26461346
[Presentation] Western blottingのプロトコール改変によるinsulin及び糖尿病関連ペプチドホルモンの定量検出の実現2017
- Author(s)
  沖田直之, 樋上賀一, 深井文雄, 小林正樹, 御手洗光来, 関谷剛男, 佐々木敬
- Organizer
  第60回日本日本糖尿病学会学術集会（5月、名古屋）
- Data Source
  KAKENHI-PROJECT-26461346
[Presentation] 健常者における麦飯と主菜の併用による食後血糖上昇の検討2017
- Author(s)
  小川篤美, 石崎知子, 細田暁彦, 種村陽子, 篠田良行, 赤石定典, 湯浅愛, 小沼宗大, 濱裕宣, 佐々木敬, 吉田博
- Organizer
  第12回日本機能性食品医用学会総会（12月、京都）
- Data Source
  KAKENHI-PROJECT-26461346
[Presentation] リラグルチド単独で血糖コントロール不十分な2型糖尿病患者へのルセオグリフロジン追加投与時の長期安全性・有効性に関する検討2017
- Author(s)
  矢部大介, 佐々木敬, 深津敦司, 今関寿恵, 落合秀和, 坂井荘一, 清野裕
- Organizer
  第60回日本日本糖尿病学会学術集会（5月、名古屋）
- Data Source
  KAKENHI-PROJECT-26461346
[Presentation] SGLT2阻害薬による治療に伴う体組成の変化と代謝の連関　52週間の前向き研究LIGHT Study2017
- Author(s)
  佐々木敬, 菅原正弘, 福田正博
- Organizer
  第60回日本日本糖尿病学会学術集会（5月、名古屋）
- Data Source
  KAKENHI-PROJECT-26461346
[Presentation] SGLT2阻害薬による治療に伴う体組成変化と代謝の連関　LIGHT study2017
- Author(s)
  佐々木敬
- Organizer
  第31回日本臨床内科医学会（10月、大阪）
- Invited
- Data Source
  KAKENHI-PROJECT-26461346
[Presentation] 日本人1型糖尿病家系における非HLA遺伝子の連鎖と両親からの遺伝様式の検討2017
- Author(s)
  根本昌実, 溝渕杏子, 佐々木敬, 藤本啓, 比企能人, 大橋十也, 宇都宮一典
- Organizer
  第21回日本適応医学会学術集会（12月、東京）
- Data Source
  KAKENHI-PROJECT-26461346
[Presentation] 教育講演：　β細胞におけるインスリン分泌の制御機構2015
- Author(s)
  佐々木　敬
- Organizer
  第58回日本糖尿病学会年次学術集会
- Place of Presentation
  山口
- Year and Date
  2015-05-21
- Invited
- Data Source
  KAKENHI-PROJECT-26461346
[Presentation] PKCdelta is a key regulator of palmitate-induced beta cell death.2015
- Author(s)
  Masatsugu Shiozaki ,Kei Fujimoto, Takashi Sasaki, Yoshida K, Kazunori Utsunomiya
- Organizer
  51st European Association for the Study of Diabetes (EASD) annual meeting
- Place of Presentation
  Stockholm, Sweden
- Year and Date
  2015-09-14
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-26461346
[Presentation] In vivo gene delivery by pancreatic direct injection of rAAV8 vector is efficient to the injured islets2007
- Author(s)
  Hiki, Y., Sasaki, T., et. al.
- Organizer
  Scientific sessions of 67th American Diabetes Association
- Place of Presentation
  Chicago, USA
- Year and Date
  2007-06-25
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-17590948
[Presentation] In vivo gene delivery by pancreatic direct injection of rAAV8 vector is efficient to the injured islets2007
- Author(s)
  比企能人、佐々木敬、根本昌実、藤本啓, ほか
- Organizer
  第67回米国糖尿病学会
- Place of Presentation
  Chicago,IL,USA
- Year and Date
  2007-06-25
- Description
  「研究成果報告書概要(和文)」より
- Data Source
  KAKENHI-PROJECT-17590948
[Presentation] Genetic association of Pro197Leu allele at GPX-1 gene to coronary artery calcification suggests importance of shifted redox balance for development of atherosclerosis in diabetes2006
- Author(s)
  根本昌実、佐々木敬、藤本啓、比企能人, ほか
- Organizer
  第42回ヨーロッパ糖尿病学会
- Place of Presentation
  Copenhagen,Denmark
- Year and Date
  2006-09-15
- Description
  「研究成果報告書概要(和文)」より
- Data Source
  KAKENHI-PROJECT-17590948
[Presentation] Genetic association of Pro 197Leu allele at GPX-1 gene to coronary artery calcification suggests importance of shifted redox balance for development of athero-sclerosis in diabetes2006
- Author(s)
  Nemoto, M., Sasaki, T., et. al.
- Organizer
  42nd Annual Meeting of the European Association for the Study of Diabetes
- Place of Presentation
  Copenhagen, Denmark
- Year and Date
  2006-09-15
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-17590948

1. NEMOTO Masami (10281396)

# of Collaborated Projects: 3 results

# of Collaborated Products: 9 results
2. TAJIMA Naoko (70112836)

# of Collaborated Projects: 2 results

# of Collaborated Products: 0 results
3. FUJIMOTO Kei (40372974)

# of Collaborated Projects: 2 results

# of Collaborated Products: 8 results
4. AIZAWA Masuo (00016742)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
5. YANAGIDA Yasuko (10282849)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
6. OHNO Tsuneya (60147288)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
7. NAKAMURA Mariko (40237433)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
8. Kouno Midori

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
9. Yoshizawa Yukio

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results

Sasaki Takashi 佐々木 敬

佐々木 敬 ササキ タカシ

SASAKI Takashi 佐々木 敬

Research Projects

Research Products

Co-Researchers

Function-structure relationship; role of the islet Schwann cellsPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Inhibition of injury and promotion of regeneration in pancreatic islets of diabetes mellitus the by molecular interventionPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Cell therapy for diabetes applied by pancreatic duct cells.

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Design and construction of cell device for inslin release to control of glycemia

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Gene Therapy for diabetes mellitus with non-endocrine cellsPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Genomic imprinting and instability in IDDMPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

日本人IDDMの遺伝におけるgenetic imprinting

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

[Journal Article] SGLT2 inhibitor-induced changes in body composition and simultaneous changes in metabolic profile: 52-week prospective LIGHT Study with Luseogliflozin.2018

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Sodium-glucose cotransporter-2 inhibitor luseogliflozin added to glucagon-like peptide 1 receptor agonist liraglutide improves glycemic control with bodyweight and fat mass reductions in Japanese patients with type 2 diabetes: A 52-week, open-label, single-arm study.2018

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Pharmacokinetics and Pharmacodynamics of Luseogliflozin, a Selective SGLT2 Inhibitor, in Japanese Patients With Type 2 Diabetes With Mild to Severe Renal Impairment.2018

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Sarcopenia, frailty circle and treatment with sodium-glucose cotransporter 2 inhibitors.2018

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Efficacy and safety of luseogliflozin added to insulin therapy in Japanese patients with type 2 diabetes: a multicenter, 52-week, clinical study with a 16-week, double-blind period and a 36-week, open-label period.2018

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Sodium-glucose cotransporter 2 inhibitor-induced changes in body composition and simultaneous changes in metabolic profile: 52-week prospective LIGHT (Luseogliflozin: the Components of Weight Loss in Japanese Patients with Type 2 Diabetes Mellitus) Study.2018

Author(s)

Journal Title

Data Source

[Journal Article] SGLT2阻害薬ルセオグリフロジンの高齢2型糖尿病患者における安全性と有効性の検討 高齢者における特定使用成績調査(最終報告)2017

Author(s)

Journal Title

Sasaki Takashi 佐々木敬

佐々木敬ササキタカシ

SASAKI Takashi 佐々木敬

[Journal Article] SGLT2阻害薬ルセオグリフロジンの高齢2型糖尿病患者における安全性と有効性の検討　高齢者における特定使用成績調査(最終報告)2017

[Journal Article] SGLT2阻害薬によるケトン体の上昇の意味は?　心血管イベントのリスク減少機序としては、高ケトンよりも血圧低下、体液減少、交感神経の過緊張の解除が有力2017

[Journal Article] 日本人2型糖尿病患者に対するSGLT2阻害薬ルセオグリフロジンの増量効果の検討　国内第III相52週投与試験の併合解析2017

[Presentation] SGLT2阻害薬ルセオグリフロジンの長期使用における安全性と有用性の検討　長期使用に関する特定使用成績調査(中間報告)2017